Not yet a member?
Continuing on the issue of heparins potentially improving survival of cancer patients, other studies have suggested a survival benefit for low molecular weight heparin (LMWH) in cancer patients. The Malignancy and Low-Molecular-Weight Hepatin Therapy study (MALT, a bit of a stretch) by Klerk and colleagues (abstract here) enrolled 302 patients with [...]
0 CommentsIn a prior post we touched on some reasons why heparins, blood thinners that are given IV or under the skin (subcutaneously), may have direct anti-tumor effects that could improve cancer outcomes, and another post covered the mixed results with the oral anticoagulant (blood thinner) coumadin in cancer, most notably SCLC. [...]
0 Comments